Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVAROXABAN Cause Suspected product quality issue? 6 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Suspected product quality issue have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.0% of all adverse event reports for RIVAROXABAN.

6
Reports of Suspected product quality issue with RIVAROXABAN
0.0%
of all RIVAROXABAN reports
0
Deaths
1
Hospitalizations

How Dangerous Is Suspected product quality issue From RIVAROXABAN?

Of the 6 reports, 1 (16.7%) required hospitalization.

Is Suspected product quality issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does RIVAROXABAN Cause?

Gastrointestinal haemorrhage (20,041) Haemorrhage (6,571) Epistaxis (5,629) Rectal haemorrhage (4,501) Off label use (4,463) Haematuria (4,387) Upper gastrointestinal haemorrhage (4,247) Cerebrovascular accident (4,111) Anaemia (3,907) Acute kidney injury (3,735)

What Other Drugs Cause Suspected product quality issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (64) LEVOTHYROXINE (37) HUMAN IMMUNOGLOBULIN G (32) ESTRADIOL (30) ONABOTULINUMTOXINA (30) SODIUM (30) CLONAZEPAM (29) AFLIBERCEPT (27) INSULIN GLARGINE (27) IOPROMIDE (25)

Which RIVAROXABAN Alternatives Have Lower Suspected product quality issue Risk?

RIVAROXABAN vs RIVASTIGMINE RIVAROXABAN vs RIVOTRIL RIVAROXABAN vs RIZATRIPTAN RIVAROXABAN vs ROACTEMRA RIVAROXABAN vs ROCURONIUM

Related Pages

RIVAROXABAN Full Profile All Suspected product quality issue Reports All Drugs Causing Suspected product quality issue RIVAROXABAN Demographics